⚡ Flash Summary

BF Biosciences Limited (BFBIO) will hold a corporate briefing session via Zoom on November 21, 2025, at 10:00 a.m. to discuss the company’s financial performance. The briefing will cover the year ended June 30, 2025, and the first quarter ended September 30, 2025. Investors, shareholders, and analysts are invited to attend the virtual meeting.

📌 Key Takeaways

• 🗓️ Corporate briefing session on November 21, 2025.
• 💻 The session will be held virtually via Zoom.
• ⏰ Time: 10:00 a.m. local time.
• 🏢 BF Biosciences Limited (BFBIO) is hosting the briefing.
• 🗣️ The briefing aims to update shareholders, investors, and analysts.
• 📊 Financial performance for the year ended June 30, 2025, will be discussed.
• Q1️⃣ First quarter ended September 30, 2025, performance will be covered.
• 🔗 Zoom meeting link: https://us02web.zoom.us/j/83176945543
• 🆔 Meeting ID: 831 7694 5543
• 🤝 Attendees are requested to join with their name and institution.
• 🔇 Attendees are requested to stay on ‘Mute’ during the presentation.
• 💬 Questions can be typed in the chat box.
• ✉️ Contact info@bfbio.com or visit www.bfbio.com for more information.
• 📍 Head office is located in Raiwind, Pakistan.
• 🏦 Registered office is in Rawalpindi, Pakistan.

🎯 Investment Thesis

HOLD. Given the lack of specific financial data, it is prudent to await the information presented at the corporate briefing session. A recommendation will be made after assessing the disclosed financial performance, future outlook, and management’s guidance. Price target and time horizon will be determined based on the briefing session outcomes.